Oxford Nanopore Technologies plc ONTTF
2.62 USD -0.03 (-1.32%)
At closeNov 13, 2026, 4:00 PM EST
2.60 Day range 2.60
1.27 52-week range 3.18
- YTD
- +52.03%
- 1 year
- +46.09%
News
proactiveinvestors.com IP Group banks £21m in Oxford Nanopore divestment IP Group PLC (LSE:IPO) told investors it has banked around £21 million from a partial sale of its stake in Oxford Nanopore Technologies PLC (LSE:ONT) while retaining a holding worth more than £150…
proactiveinvestors.com Oxford Nanopore target price raised by RBC on AI opportunity RBC Capital Markets raised its target price for Oxford Nanopore Technologies PLC (LSE:ONT) to 300p from 225p, saying the sequencing company is well placed to benefit from growing demand for…
seekingalpha.com Oxford Nanopore Technologies plc (OXFYY) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript Oxford Nanopore Technologies plc (OXFYY) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
proactiveinvestors.co.uk Oxford Nanopore target price hiked to 196p by Panmure Liberum on strategic pivot Oxford Nanopore Technologies PLC (LSE:ONT) secured an upgrade to a 'buy' rating from Panmure Liberum on Monday, as analysts cheered a lucrative diagnostics deal despite lingering strategic risks. The…
seekingalpha.com Oxford Nanopore Technologies plc (OXFYY) Q2 2026 Earnings Call Transcript Oxford Nanopore Technologies plc (OXFYY) Q2 2026 Earnings Call Transcript
marketbeat.com Oxford Nanopore Technologies H1 Earnings Call Highlights Oxford Nanopore Technologies LON: ONT reported first-half revenue growth below its expectations as declines in China, the Middle East and delayed orders in the Americas weighed on performance, while…
proactiveinvestors.co.uk Oxford Nanopore sets $700m revenue target for 2030 Oxford Nanopore Technologies PLC (LSE:ONT), the DNA-sequencing technology company, has set a target of more than $700 million in annual revenue by 2030 as it maps out a path to profitability. The…
proactiveinvestors.co.uk Oxford Nanopore shares slide 16% after first-half sales miss expectations Shares in Oxford Nanopore Technologies PLC (LSE:ONT) fell 16% to 101.2 pence after the company said first-half trading had come in below management expectations. The maker of nanopore-based…
proactiveinvestors.co.uk Leading banks back Oxford Nanopore after London Calling showcases maturing platform Oxford Nanopore Technologies PLC (LSE:ONT), the LSE-listed DNA sequencing company, has drawn positive reviews from RBC Capital Markets and Citi following its annual London Calling customer conference…
businesswire.com Oxford Nanopore and A.D.A.M. Innovations Announce International Collaboration to Accelerate Advanced Genomic Medicine in Japan OXFORD, England & TOKYO--(BUSINESS WIRE)-- #Nanopore--Oxford Nanopore Technologies, the company delivering a new generation of molecular sensing technology based on nanopores, and A.D.A.M.…
seekingalpha.com Oxford Nanopore Technologies plc (ONTTF) Presents at Barclays 28th Annual Global Healthcare Conference Transcript Oxford Nanopore Technologies plc (ONTTF) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
businesswire.com ViruSure Launches First GMP-Validated Viral Safety Test Based on Oxford Nanopore Sequencing OXFORD, England & VIENNA--(BUSINESS WIRE)-- #Nanopore--ViruSure, an Asahi Kasei company and global leader in pathogen safety testing for biopharmaceuticals, today announced the launch of the world's…
proactiveinvestors.co.uk Citi keeps 'buy' rating on Oxford Nanopore as profitability target holds despite revenue miss Oxford Nanopore Technologies PLC (LSE:ONT), the DNA sequencing company, retained its 'buy' rating at Citi after reporting second-half 2025 adjusted earnings ahead of expectations, even as it issued…
seekingalpha.com Oxford Nanopore Technologies plc (ONTTF) Q4 2025 Earnings Call Transcript Oxford Nanopore Technologies plc (ONTTF) Q4 2025 Earnings Call Transcript
seekingalpha.com Oxford Nanopore Technologies plc (ONTTF) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Oxford Nanopore Technologies plc (ONTTF) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
proactiveinvestors.co.uk Oxford Nanopore rises on strong 2025 revenue growth Shares in Oxford Nanopore Technologies PLC (LSE:ONT) rose 8% to 152p on Monday after the DNA sequencing group said its revenue for 2025 would come in slightly ahead of guidance, helped by…
businesswire.com Oxford Nanopore Receives Regulatory Approval for its First Diagnostic Device in the UK and Europe OXFORD, England--(BUSINESS WIRE)-- #Nanopore--Oxford Nanopore Technologies today announces that the GridION™ Dx is now both CE and UKCA marked, making it the company's first IVD device registered in…
seekingalpha.com Oxford Nanopore Technologies plc (ONTTF) Presents at Citi Annual Global Healthcare Conference 2025 Transcript Oxford Nanopore Technologies plc (ONTTF) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
businesswire.com Oxford Nanopore Announces PromethION Plus Flow Cell and Human Genetics Updates at ASHG 2025 OXFORD, England--(BUSINESS WIRE)-- #Nanopore--At the American Society of Human Genetics (ASHG) 2025 industry session on 16th October, Oxford Nanopore Technologies will share its latest developments…
prnewswire.com Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032 Grants Bio-Techne expanded commercial rights to develop a portfolio of genetics products beyond the recently launched AmplideX® Nanopore Carrier Plus Kit Establishes a framework to define and propose…